Yüklüyor......
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence
OBJECTIVES: New antibacterial agents are required for the treatment of infections caused by multidrug-resistant (MDR) Acinetobacter spp. Whether tigecycline constitutes an effective treatment option or not, is not well established. We sought to evaluate the available evidence regarding the microbiol...
Kaydedildi:
| Yayımlandı: | J Antimicrob Chemother |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2008
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8057304/ https://ncbi.nlm.nih.gov/pubmed/18436554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkn165 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|